3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Lung Neoplasms
2
Neoplasm Metastasis
1
Liver Neoplasms
1
Gastrointestinal Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Cisplatin
66
Paclitaxel
43
Radiotherapy
39
Carboplatin
29
Fluorouracil
27
Drug Therapy
20
Irinotecan
16
toripalimab
15
pembrolizumab
15
tislelizumab
14
camrelizumab
13
sintilimab
12
Radiotherapy, Intensity-Modulated
11
Albumin-Bound Paclitaxel
11
S 1 (combination)
10
Capecitabine
10
130-nm albumin-bound paclitaxel
10
apatinib
9
Radiation
9
Oxaliplatin
9
Neoadjuvant Therapy
9
Esophagectomy
9
Docetaxel
9
nimotuzumab
8
TP protocol
8
Cetuximab
8
anlotinib
7
Nivolumab
7
nedaplatin
6
Taxes
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Esophageal Squamous Cell Carcinoma
×
Thoracoscopy
×
Clear all
NCT02188615
2014-07-11
NACRFMIE
Taizhou Hospital
Phase 2
Unknown
120 enrolled